Cwm, LLC Cara Therapeutics, Inc. Transaction History

Cwm, LLC

$20.6 Billion
Q1 2024

A detailed history of Cwm, LLC transactions in Cara Therapeutics, Inc. stock. As of the latest transaction made, Cwm, LLC holds 1,343 shares of CARA stock, worth $349. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,343

Previous 702 91.31%

Holding current value

$349

Previous $1,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 05, 2024	BUY	$0.52 - $1.05 $333 - $673	641 Added 91.31%	1,343 $1,000
Q4 2023 Feb 01, 2024	SELL	$0.6 - $1.65 $529 - $1,456	-883 Reduced 55.71%	702 $1,000
Q3 2023 Oct 11, 2023	BUY	$1.67 - $3.33 $1,369 - $2,730	820 Added 107.19%	1,585 $3,000
Q2 2023 Aug 03, 2023	SELL	$2.83 - $4.94 $987 - $1,724	-349 Reduced 31.33%	765 $2,000
Q1 2023 Apr 28, 2023	BUY	$4.89 - $12.27 $1,628 - $4,085	333 Added 42.64%	1,114 $5,000

Q4 2022 Feb 01, 2023	SELL	$8.88 - $12.77 $11,144 - $16,026	-1,255 Reduced 61.64%	781 $8,000
Q3 2022 Oct 27, 2022	SELL	$8.24 - $12.56 $370 - $565	-45 Reduced 2.16%	2,036 $19,000
Q1 2022 Apr 21, 2022	SELL	$9.94 - $12.65 $497 - $632	-50 Reduced 2.35%	2,081 $25,000
Q4 2021 Jan 31, 2022	BUY	$11.99 - $18.14 $7,637 - $11,555	637 Added 42.64%	2,131 $26,000
Q1 2021 Sep 15, 2021	BUY	$15.07 - $21.71 $6,962 - $10,030	462 Added 44.77%	1,494 $21,000
Q1 2021 Apr 27, 2021	SELL	$15.07 - $21.71 $6,962 - $10,030	-462 Reduced 30.92%	1,032 $22,000
Q4 2020 Sep 15, 2021	BUY	$12.72 - $16.16 $10,074 - $12,798	792 Added 112.82%	1,494 $21,000
Q4 2020 Jan 27, 2021	SELL	$12.72 - $16.16 $10,074 - $12,798	-792 Reduced 53.01%	702 $11,000
Q3 2020 Sep 15, 2021	BUY	$12.34 - $17.92 $9,773 - $14,192	792 Added 112.82%	1,494 $21,000
Q3 2020 Oct 19, 2020	SELL	$12.34 - $17.92 $9,773 - $14,192	-792 Reduced 53.01%	702 $9,000
Q2 2020 Sep 15, 2021	BUY	$12.39 - $17.33 $9,812 - $13,725	792 Added 112.82%	1,494 $21,000
Q2 2020 Jul 22, 2020	SELL	$12.39 - $17.33 $9,812 - $13,725	-792 Reduced 53.01%	702 $12,000
Q1 2020 Sep 15, 2021	BUY	$9.12 - $17.78 $7,223 - $14,081	792 Added 112.82%	1,494 $21,000
Q1 2020 Apr 28, 2020	SELL	$9.12 - $17.78 $7,223 - $14,081	-792 Reduced 53.01%	702 $9,000
Q4 2019 Sep 14, 2021	BUY	$16.11 - $25.98 $24,068 - $38,814	1,494 New	1,494 $21,000
Q4 2019 Jan 27, 2020	SELL	$16.11 - $25.98 $24,068 - $38,814	-1,494 Closed	0 $0
Q3 2019 Sep 14, 2021	BUY	$18.28 - $26.91 $27,310 - $40,203	1,494 New	1,494 $21,000
Q3 2019 Oct 22, 2019	SELL	$18.28 - $26.91 $27,310 - $40,203	-1,494 Closed	0 $0
Q2 2019 Sep 14, 2021	BUY	$17.68 - $21.57 $26,413 - $32,225	1,494 New	1,494 $21,000
Q2 2019 Jul 31, 2019	SELL	$17.68 - $21.57 $26,413 - $32,225	-1,494 Closed	0 $0
Q1 2019 Sep 02, 2021	BUY	$14.41 - $19.64 $21,528 - $29,342	1,494 New	1,494 $0

Others Institutions Holding CARA

# of Institutions

102

Shares Held

21.5M

Call Options Held

50K

Put Options Held

View Full List

About Cara Therapeutics, Inc.

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $14M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

More about CARA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.

Account